Thor G. Theander

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications

Sex-specific signatures of fetal programming for gestational diabetes mellitus in umbilical cord: A cohort study from Tanzania.

Sex-specific signatures of fetal programming for gestational diabetes mellitus in umbilical cord: A cohort study from Tanzania.

Journal: BMC medicine
Published: January 25, 2026

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Journal: Gut
Published: November 15, 2025

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Journal: Scientific reports
Published: September 30, 2025

Identification of broadly inhibitory anti-PfEMP1 antibodies by mass spectrometry sequencing of plasma IgG from a malaria-exposed child.

Identification of broadly inhibitory anti-PfEMP1 antibodies by mass spectrometry sequencing of plasma IgG from a malaria-exposed child.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 20, 2025

Kinetics of antimalarial antibodies in children with common haemoglobinopathies in a Tanzanian population.

Kinetics of antimalarial antibodies in children with common haemoglobinopathies in a Tanzanian population.

Journal: Frontiers in immunology
Published: August 14, 2025

Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.

Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.

Journal: Cell death & disease
Published: May 14, 2025

Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate.

Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate.

Journal: NPJ precision oncology
Published: January 17, 2025

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML.

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML.

Journal: Blood
Published: December 20, 2024

The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

Journal: Blood
Published: December 20, 2024

Changing Plasmodium falciparum malaria prevalence in two villages of northeastern Tanzania between 2003 and 2021 in relation to vectors, interventions and climatic factors.

Changing Plasmodium falciparum malaria prevalence in two villages of northeastern Tanzania between 2003 and 2021 in relation to vectors, interventions and climatic factors.

Journal: Malaria journal
Published: October 17, 2024

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Journal: STAR protocols
Published: October 11, 2024

Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma.

Use of the Malaria Protein VAR2CSA for the Detection of Small Extracellular Vesicles to Diagnose Adenocarcinoma.

Journal: Journal of extracellular vesicles
Published: July 29, 2024
Showing 1-12 of 108

Last Updated: 09/26/2026